Advertisement
Anteris Technologies Global Corp.

Anteris Technologies Global Corp. (AVR) Stock Overview

Explore Anteris Technologies Global Corp.โ€™s financial performance, market position, analyst ratings, and future outlook.

AVRโ—NASDAQ
HealthcareMedical - Devices
$9.65
$0.31(3.34%)
U.S. Market is Open ยท 14:31
Advertisement

Anteris Technologies Global Corp. (AVR)

Meyka AI Score

Z

Key Financials

Market Cap348.4M
P/E Ratio-2.33
EPS (TTM)$-2.22
ROE-1.24%
Fundamental Analysis

AI Price Forecasts

1 Month$7.18
3 Months$7.93
1 Year Target$8.37

AVR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Anteris Technologies Global Corp. (AVR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 66.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $8.37.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.33 and a market capitalization of 348.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.39%
5-Day Change
4.30%
1-Month Change
43.92%
3-Month Change
59.70%
6-Month Change
100.21%
Year-to-Date (YTD) Change
89.78%
1-Year Change
76.35%
3-Year Change
69.11%
5-Year Change
69.11%
All-Time (Max) Change
69.11%

Contact Information

61 13 0055 0310
Toowong Tower, Toowong, QLD, 4066

Company Facts

136 Employees
IPO DateDec 13, 2024
CountryAU
Actively Trading

Frequently Asked Questions